Kunming Longjin Pharmaceutical Co Ltd (002750) — Capital Reinvestment Ratio
Kunming Longjin Pharmaceutical Co Ltd (002750) has a Capital Reinvestment Ratio of 6.23x as of December 2022, meaning it reinvests 6% of its operating cash flow (CN¥867.54K) in capital expenditures (CN¥5.41 Million). Check 002750 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Kunming Longjin Pharmaceutical Co Ltd Capital Reinvestment Ratio (2011–2019)
This chart tracks Kunming Longjin Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 9 annual periods. For the full cash flow conversion analysis, see how efficiently does Kunming Longjin Pharmaceutical Co Ltd generate cash.
Annual Capital Reinvestment Ratio for Kunming Longjin Pharmaceutical Co Ltd (2011–2019)
Year-by-year Capital Reinvestment Ratio for Kunming Longjin Pharmaceutical Co Ltd from 2011 to 2019. See Kunming Longjin Pharmaceutical Co Ltd (002750) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 1.75x | CN¥4.04 Million | CN¥7.07 Million | ▲ +257.1% |
| 2018 | 0.49x | CN¥31.70 Million | CN¥15.53 Million | ▲ +62.2% |
| 2017 | 0.30x | CN¥58.06 Million | CN¥17.54 Million | ▲ +33.7% |
| 2016 | 0.23x | CN¥104.24 Million | CN¥23.56 Million | ▼ -33.7% |
| 2015 | 0.34x | CN¥70.19 Million | CN¥23.93 Million | ▲ +29.5% |
| 2014 | 0.26x | CN¥70.16 Million | CN¥18.47 Million | ▼ -52.9% |
| 2013 | 0.56x | CN¥106.46 Million | CN¥59.57 Million | ▼ -31.2% |
| 2012 | 0.81x | CN¥91.16 Million | CN¥74.14 Million | ▼ -33.5% |
| 2011 | 1.22x | CN¥75.90 Million | CN¥92.79 Million | — |